9,10-dimethyl-1,2-benzanthracene has been researched along with Leukocytopenia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Chen, W; Luo, D; Wang, W; Wang, Y; Xia, Y | 1 |
1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Leukocytopenia
Article | Year |
---|---|
Amelioration of cyclophosphamide-induced myelosuppression during treatment to rats with breast cancer through low-intensity pulsed ultrasound.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Blood Cell Count; Bone Marrow; Carcinogens; Cyclophosphamide; Disease Models, Animal; Female; Femur; Hematopoiesis; Humans; Injections, Intraperitoneal; Leukopenia; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Ultrasonic Therapy | 2020 |